Clinical Trial: Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.

U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040930) titled 'Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.' on June 10.

Brief Summary: This study is designed to evaluate the safety, tolerability, PK and PD of multiple subcutaneous injections of GenSci120 in a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase Ib trial involving healthy adult participants.

Study Start Date: July 31

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis

Intervention: DRUG: GenSci120

a total of 3 doses of the investigational medicinal product (IMP) SC every...